ALK-Brain Prognostic Index-Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases.

Georgios TsakonasCaroline KamaliLuigi De PetrisSigne FrieslandRolf LewensohnSimon Ekman

Published in: Cancers (2020)

We propose the ALK-BPI score as a new prognostic tool that can easily be applied for ALK-positive lung cancer patients with brain metastases in daily clinical practice, as it has at least the same prognostic value as Lung-molGPA.

Keyphrases

brain metastases
small cell lung cancer
advanced non small cell lung cancer
clinical practice
physical activity
epidermal growth factor receptor
white matter
blood brain barrier
resting state